These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 37652400)
1. DNA Methylation Signature of Synchronous Endometrioid Endometrial and Ovarian Carcinomas. Hsu Lin L; Allison DHR; Turashvili G; Vasudevaraja V; Tran I; Serrano J; Weigelt B; Ladanyi M; Abu-Rustum NR; Snuderl M; Chiang S Mod Pathol; 2023 Nov; 36(11):100321. PubMed ID: 37652400 [TBL] [Abstract][Full Text] [Related]
2. Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas. Schultheis AM; Ng CK; De Filippo MR; Piscuoglio S; Macedo GS; Gatius S; Perez Mies B; Soslow RA; Lim RS; Viale A; Huberman KH; Palacios JC; Reis-Filho JS; Matias-Guiu X; Weigelt B J Natl Cancer Inst; 2016 Jun; 108(6):djv427. PubMed ID: 26832770 [TBL] [Abstract][Full Text] [Related]
3. Molecular evidence for a clonal relationship between synchronous uterine endometrioid carcinoma and ovarian clear cell carcinoma: a new example of "precursor escape"? Weng CH; Wu RC; Chen SJ; Chen HC; Tan KT; Lee YS; Huang SS; Yang LY; Wang CJ; Chou HH; Chao AS; Chao A; Lai CH J Mol Med (Berl); 2021 Jul; 99(7):959-966. PubMed ID: 33768299 [TBL] [Abstract][Full Text] [Related]
4. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas. Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321 [TBL] [Abstract][Full Text] [Related]
5. Implication of genomic characterization in synchronous endometrial and ovarian cancers of endometrioid histology. Chao A; Wu RC; Jung SM; Lee YS; Chen SJ; Lu YL; Tsai CL; Lin CY; Tang YH; Chen MY; Huang HJ; Chou HH; Huang KG; Chang TC; Wang TH; Lai CH Gynecol Oncol; 2016 Oct; 143(1):60-67. PubMed ID: 27498588 [TBL] [Abstract][Full Text] [Related]
7. Molecular profiling and molecular classification of endometrioid ovarian carcinomas. Cybulska P; Paula ADC; Tseng J; Leitao MM; Bashashati A; Huntsman DG; Nazeran TM; Aghajanian C; Abu-Rustum NR; DeLair DF; Shah SP; Weigelt B Gynecol Oncol; 2019 Sep; 154(3):516-523. PubMed ID: 31340883 [TBL] [Abstract][Full Text] [Related]
8. Synchronous Endometrial and Ovarian Carcinomas: Pathologic and Molecular Analysis Highlights the Monoclonal Origin of the Lesions. Guerriero A; Moro M; Angerilli V; Munari G; Santoro L; Alessandrini L; Favero L; Tasca G; Fassan M; Dei Tos AP Int J Gynecol Pathol; 2024 Jul; 43(4):309-315. PubMed ID: 37922918 [TBL] [Abstract][Full Text] [Related]
9. High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma. Ishikawa M; Nakayama K; Nakamura K; Ono R; Yamashita H; Ishibashi T; Minamoto T; Iida K; Razia S; Ishikawa N; Kyo S Hum Pathol; 2019 Mar; 85():92-100. PubMed ID: 30448219 [TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411 [TBL] [Abstract][Full Text] [Related]
11. The sensitivity and specificity of a new formula to distinguish endometrioid type endometrial carcinoma from ovarian endometrial carcinoma. Nishimura S; Ito YM; Tsuda H; Ohnishi Y; Kataoka F; Nomura H; Chiyoda T; Suzuki A; Susumu N; Aoki D; Hatae M Eur J Obstet Gynecol Reprod Biol; 2010 Jan; 148(1):67-72. PubMed ID: 19815329 [TBL] [Abstract][Full Text] [Related]
12. Elucidating the pathogenesis of synchronous and metachronous tumors in a woman with endometrioid carcinomas using a whole-exome sequencing approach. Wu RC; Veras E; Lin J; Gerry E; Bahadirli-Talbott A; Baras A; Ayhan A; Shih IM; Wang TL Cold Spring Harb Mol Case Stud; 2017 Nov; 3(6):. PubMed ID: 29162652 [TBL] [Abstract][Full Text] [Related]
13. Methylation profiles of endometrioid and serous endometrial cancers. Seeber LM; Zweemer RP; Marchionni L; Massuger LF; Smit VT; van Baal WM; Verheijen RH; van Diest PJ Endocr Relat Cancer; 2010 Sep; 17(3):663-73. PubMed ID: 20488783 [TBL] [Abstract][Full Text] [Related]
14. The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas. Zhan X; Li L; Wu M; Lang J Arch Gynecol Obstet; 2019 Oct; 300(4):1045-1052. PubMed ID: 31520260 [TBL] [Abstract][Full Text] [Related]
15. Synchronous ovarian endometrioid adenocarcinoma with a functioning stroma and endometrial endometrioid adenocarcinoma by different loss of heterozygosity findings. Takai N; Kai K; Tsuno A; Nasu K; Kashima K; Narahara H Arch Gynecol Obstet; 2011 Oct; 284(4):951-5. PubMed ID: 21046134 [TBL] [Abstract][Full Text] [Related]
16. Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles. McConechy MK; Ding J; Senz J; Yang W; Melnyk N; Tone AA; Prentice LM; Wiegand KC; McAlpine JN; Shah SP; Lee CH; Goodfellow PJ; Gilks CB; Huntsman DG Mod Pathol; 2014 Jan; 27(1):128-34. PubMed ID: 23765252 [TBL] [Abstract][Full Text] [Related]
17. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset. Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223 [TBL] [Abstract][Full Text] [Related]
18. CTNNB1 p.L31P mutation in an ovarian endometrioid carcinoma with synchronous uterine endometrioid carcinoma. Pecorella I; Coppa A; Nicolussi A; Manganaro L; Fiorentin F; Palaia I; Muzii L Pathol Res Pract; 2020 Dec; 216(12):153260. PubMed ID: 33120166 [TBL] [Abstract][Full Text] [Related]
19. Does synchronous endometrioid endometrial cancer have any prognostic effect on Stage I endometrioid ovarian cancer? Narin MA; Karalok A; Basaran D; Ureyen I; Turkmen O; Turan T; Tulunay G Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():113-6. PubMed ID: 27017531 [TBL] [Abstract][Full Text] [Related]
20. Mesonephric-like adenocarcinoma harbours characteristic copy number variations and a distinct DNA methylation signature closely related to mesonephric adenocarcinoma of the cervix. Kommoss FK; Lee CH; Tessier-Cloutier B; Gilks CB; Stewart CJ; von Deimling A; Köbel M J Pathol; 2024 Jan; 262(1):4-9. PubMed ID: 37850576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]